Bectas Therapeutics has filed a notice of an exempt offering of securities to raise $10 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Bectas Therapeutics is raising up to $10 Million in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Ronan…